key: cord-0003789-a334btay authors: Cheng, Jing; Zheng, Jia; Liu, Yanping; Hao, Panpan title: Efficacy of traditional Chinese medication Tangminling pill in Chinese patients with type 2 diabetes date: 2019-04-30 journal: Biosci Rep DOI: 10.1042/bsr20181729 sha: e1ea07d20c6b64c1eae05319f1f66f729f2583d9 doc_id: 3789 cord_uid: a334btay The morbidity of type 2 diabetes mellitus (T2DM) has been increasing rapidly worldwide. Tangminling pill, consisting of ten Chinese herbal medications, is usually prescribed for T2DM in mainland China. Whether treatment with Tangminling can improve clinical outcomes of T2DM patients was still debated. Four studies comparing Tangminling vs. placebo treatment in T2DM patients were included and 767 T2DM patients were enrolled in our analyses. Tangminling treatment exhibited better efficacy than placebo in reducing hemoglobin A1c (HbA1c) (1.11 vs. 0.32%; pooled weighted mean difference [WMD]: 0.80; 95% confidence interval [CI]: 0.65–0.96; P<0.001), fasting plasma glucose (0.82 vs. −0.40 mM; WMD: 1.10; 95% CI: 0.56–1.64; P<0.001), 2-h postprandial glucose (2-hr PG) (2.81 vs. 1.11 mM; WMD: 1.80; 95% CI: 1.72–1.88; P<0.001), homeostatic model assessment-β level (4.28 vs. 0.41; WMD: 0.44; 95% CI: 0.27–0.61; P<0.001), waist circumference (WC) (1.04 vs. 0.36 cm; WMD: 0.78; 95% CI: 0.37–1.19; P<0.001) and body weight index (0.37 vs. 0.11 kg/m(2); WMD: 0.30; 95% CI: −0.00 to 0.61; P=0.05). Tangminling pill might reduce glucose level and body weight and improve β-cell function in T2DM patients. Our study highlights the important role of Tangminling pill in the management of T2DM. Type 2 diabetes mellitus (T2DM) is becoming a crucial threat to human health, with approximately 425 million individuals worldwide in 2017, and it is estimated that the number will exhibit a 45% increase in three decades [1] . T2DM patients might be suffering from pancreatic β-cell dysfunction and reduced insulin sensitivity in target tissues [2, 3] . Chronic hyperglycemia causes macrovascular and microvascular complications and remodeling in the heart, kidneys, eyes, and nerves [4] [5] [6] . Oral antidiabetic agents, including metformin, sulfonylureas, glucosidase inhibitors, thiazolidinediones, meglitinides, and inhibitors of dipeptidyl peptidase 4, have substantially improved the prognosis of most T2DM patients. However, the efficacy of Western medications remains deficient in certain patients and vastly disproportionate burden on patients in low-and middle-income countries. Hence, complementary or alternative therapies such as traditional Chinese herbal medications are required to prolong life expectancy and improve the quality of life in T2DM patients. Although traditional Chinese herbal medications have been widely used for more than 2000 years in East Asia and previous studies suggested that some Chinese herbal medications were effective in treating T2DM [7] [8] [9] , their evidence based on randomized controlled trials (RCTs) is still feeble. Tangminling pill, mainly containing Rhizoma coptidis, Rheum officinale Baill, Scutellaria baicalensis Georgi, and Bupleurum Chinense DC, might reduce blood glucose level and improve pancreatic β-cell function [8, [10] [11] [12] . However, the studies focusing on the effects of Tangminling pill on T2DM were limited due to insufficient sample sizes and inconclusive results. In our study, we performed a pooled analysis to evaluate the effects of Tangminling pill on blood glucose, body weight, and β-cell function in T2DM patients. The pharmaceutical composition of Tangminling pill comprises extracts of the following ten traditional Chinese herbs: Rhizoma coptidis (Huanglian), Scutellaria baicalensis Georgi (Huangqin), Radix Paeoniae Alba (Baishao), Rheum officinale Baill (Dahuang), Citrus aurantium L (Zhishi), Pinellia ternate (Baixia), Crataegus pinnatifida Bunge (Shanzha), Smoked plum Fructus mume (Wumei), Radix Trichosanthis (Tianhuafen), and Bupleurum Chinense DC (Chaihu), and optionally comprises pharmaceutically acceptable excipient. The method to prepare Tangminling pill and the doses of all the above ten crude herbs have been disclosed to the public (http: //www.freepatentsonline.com/8637092.html). It was manufactured and capsulated with specific processing of Chinese herbal medicine in Tasly Pharmaceutical (Tianjin, China), as described previously [8] . There were quantitative control limits for the raw herbs in the final product (the content of berberine in Rhizoma coptidis shall not be <6.0 mg/g and the content of paeoniflorin in Radix Paeoniae Alba shall not be <3.0 mg/g). The chemical composition of Tangminling pill was further analyzed using the high-performance liquid chromatography/mass spectrometry (HPLC/MS) method [8] . The study project conformed to the ethical rules of the Helsinki Declaration (revised edition in October 2013) and was approved by the Ethics Committee of Shandong University Qilu Hospital (KYLL-201761; date of approval: 15 July 2017). Relevant RCTs were identified from the following data sources: Medline, China VIP, China National Knowledge Internet, China Wanfang, and Cochrane library. Literature were searched with the terms ('Tang-min-ling' or 'TM81' or 'Tangminling' or 'TML') AND ('diabetes' or 'T2DM'). Publication status, language, and date were not restricted. We included studies with the following criteria: (i) compared Tangminling treatment vs. placebo treatment in T2DM patients; (ii) RCTs with more than 1-month follow-up durations; and (iii) contained available data to estimate the pooled weighted mean differences (WMDs) and their corresponding 95% confidence intervals (CIs). Studies were excluded as follows: (i) diagnosis of T2DM was not definite; (ii) studies were non-randomized and/or non-double-blinded; (iii) different traditional Chinese medications were compared between two groups; (iv) only symptomatic changes were described without objective laboratory measurements; (v) methodological quality was poor with a Jadad score < 3 as described previously [13] ; and (vi) if two articles reported results from the same trial, the article with less information was excluded. We extracted the following information from retrieved reports using a standardized protocol: author names, publication dates, study designs, countries of origin, subject numbers, subject characteristics at baseline, follow-up durations, concomitant medications, and end points [14] . The literature search and data extraction were performed blindly by two authors (J.C. and Y.L.) according to a standardized approach. All disagreements were resolved by consensus and a third reviewer (P.H.). RevMan software version 5.3 was used for this pooled analysis. The heterogeneity was evaluated by the Cochran's Q statistic and the inconsistency index (I 2 ). Heterogeneity was considered statistically significant when chi-square P was <0.10 and I 2 was >50%. Pooled WMDs with 95% CIs were analyzed, and the difference was considered statistically significant when two-tailed P was <0.05. Moreover, sensitivity analyses were performed to evaluate individual effects and explain possible heterogeneity. Additionally, we calculated the fail-safe number (Nfs; N fs0.05 = (ࢣZ/1.64) 2 -k, where k is the number of retrieved studies) to assess publication bias [15] . Any N fs0.05 values smaller than the number of included trials indicated that obvious publication bias existed. [8, 10, 12] Abbreviations: BMI, body weight index; HOMA-β, homeostatic model assessment to β-cell function; HOMA-IR, homeostatic model assessment to quantitate insulin resistance; PG, postprandial plasma glucose; WC, waist circumference. Two hundred and seventy eight potentially literature citations were screened. Only four RCTs with sufficient information were included for analyses, and all the four RCTs were published in full articles updated to December 2017 [8, [10] [11] [12] . The agreement for literature selection was excellent (κ = 0.93). Seven hundred and sixty seven T2DM patients were enrolled in our pooled analyses, with 71-397 participants in the four eligible trials. The mean ages of the participants ranged from 51.6 to 54.5 years, and the follow-up durations were all 12 weeks. The Jadad scores were five in three of four RCTs [10] [11] [12] and four in the left one RCT [8] . The loss to follow-up was <10% in all RCTs. Thus, the methodological quality of the retrieved studies was generally high. First, we performed a pooled analysis to evaluate the effect of Tangminling pill on blood glucose level. Blood glucose improvement was evaluated by reductions of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG) and 2-h postprandial glucose (2-hr PG) levels from baseline in all four studies ( Furthermore, it showed that Tangminling pill significantly improved pancreatic β-cell function, expressed as homeostatic model assessment (HOMA)-β decrease from baseline (Table 1) . Although there was no difference in reducing HOMA-insulin resistance (IR) between Tangminling and placebo groups (0.16 vs. −0.16, P>0.05), Tangminling significantly decreased HOMA-β level from baseline as compared with placebo (4.28 vs. 0.41, P<0.001). Furthermore, the safety of Tangminling pill was also confirmed, without serious adverse events reported in all the four RCTs. Heterogeneity was well-addressed in terms of HbA1c (I 2 = 0%), 2h-PG (I 2 = 0%), and HOMA-β (I 2 = 36%). However, significant heterogeneity was existed in terms of FPG (I 2 = 77%), BMI (I 2 = 90%), WC (I 2 = 63%), and HOMA-IR (I 2 = 81%). Alterations in pooled WMDs were not significant after excluding the study with the largest sample size [8] (data not shown). Thereafter, subgroup analyses according to FPG, BMI, WC, and HOMA-IR were conducted ( Table 2 ). The heterogeneity among trials was partially explained by the variability in doses of the medication and subject numbers. Publication bias N fs0.05 values for HbA1c, FPG, 2-hr PG, BMI, WC, HOMA-β, and HOMA-IR were higher than the number of studies included in the corresponding analyses, indicating negligible publication bias in our analyses. The pooled analyses indicated that Tangminling pill was more efficacious in decreasing glucose level, body weight, and improving β-cell function, with no more drug-related adverse events, than placebo treatment in T2DM patients. Traditional Chinese medications, mainly edible herbs, have been widely used in clinical practice in China for more than 2000 years [16] [17] [18] . Ten traditional Chinese herbs were extracted and included in Tangminling (Table 3) . Three bioactive alkaloids have been isolated from Rhizoma coptidis, including berberine, coptisine, and jatrorrhizine. Berberine has numerous pharmacological effects with anti-diabetic, anti-inflammatory, anti-hypercholesterolemia, and cardioprotective properties [19] [20] [21] [22] [23] . Berberine displays beneficial actions in the treatment of insulin-resistant and hyperglycemic states by up-regulating adipose triglyceride lipase in adipocytes via activating adenosine 5 -monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway [24, 25] . It might improve glucose metabolism via inhibiting oxidation and aldose reductase. Besides, berberine might exert its anti-inflammatory action through AMPK activation, nuclear factor-κB (NF-κB) inhibition, and AP-1 pathway inhibition [26, 27] . Coptisine is another bioactive component of Rhizoma coptidis, and it exhibits antioxidation, anti-osteosarcoma, anti-inflammation, neuroprotection, and anti-cancer actions through preventing interleukin-1β (IL-1β) expression, activating Akt and c-Jun N-terminal kinase (JNK)/nuclear factor erythroid 2-related factor 2 (Nrf2)/NAD(P)H:quinine oxidoreductase 1 (NQO1) signaling pathways and inhibiting lipopolysaccharide (LPS)/toll-like receptor-4 (TLR-4)-mediated pathway [28] [29] [30] [31] [32] . Rheum officinale Baill, the root and rhizome of Rheum palmatum L, has antioxidant, anti-platelet aggregation, and anti-inflammatory properties [33] [34] [35] . The underlying mechanism might involve reductions in the mRNA expressions of acidic mammalian chitinase and chitinase 3-like protein 4 as well as inhibition of the progression of inflammation [35] . Bupleurum Chinense DC and its bioactive ingredients, saikosaponins, exhibited immunomodulatory [36] , antiviral [37] , hepatoprotective [38] , and anti-cancer [39] effects through inducing cell cycle arrest and cell apoptosis [40] . Moreover, albiflorin, which was extracted from Radix Paeoniae Alba or Paeonia lactiflora, exerted anti-depressant and anti-allergic effects through biosynthesis of allopregnanolone and inhibition of mast cell activation [41, 42] . The main active ingredients of Scutellaria baicalensis Georgi are baicalin and wogonin, which exhibited protection of diabetes and its complications. Berberine -anti-inflammatory [23, 24] ; -anti-hypercholesterolemia [21, 22] ; blood glucose-lowering [20] ; -anti-obesity [21] ; -cardioprotective [19] ; and antioxidative [17] -inhibiting PPAR-γ and C/EBP-α [21] ; increasing adipose triglyceride lipase [20] ; -inhibiting NF-κB [23, 24] ; AMPK activation [22] [23] [24] Cell cultures; rodent models Coptisine -antioxidative [25] ; -anti-inflammatory [26] ; -neuroprotective [27] ; -anti-obesity [28] ; and anti-cancer [29] -preventing IL-1β expression; activating Akt and JNK/Nrf2/NQO1 pathway [25] ; -inhibiting LPS/TLR-4-mediated signaling pathway [28] Cell cultures; rodent models Rheum officinale Baill Rhubarb -antioxidative [30] ; -anti-platelet aggregation [31] and anti-inflammatory [32] -regulating inflammatory mediators [32] Cell cultures; rodent models -immunomodulatory [33] ; antiviral [34] ; -hepatoprotective [35] ; -anti-cancer [36] -cell cycle arrest and induction of apoptosis [37] Cell cultures; rodent models Albiflorin -antidepressant [38] and anti-allergic [39] -allopregnanolone biosynthesis; -inhibition of mast cell activation [39] Cell cultures; rodent models Baicalin -anti-fibrosis [40] ; lipid-lowing; anti-hyperglycemic [41] ; -alleviating diabetes-associated cognitive deficits [44] -modulating TGF-β/Smad signaling pathway [40] ; -promoting islet β-cell function [41] ; -modulation of MAPK sighnaling [44] Cell cultures; rodent models Wogonin -cardioprotective [42] ; -anti-inflammatory [42] ; -antioxidative [42] ; -anti-hyperglycemic and lipid-lowering [43] -activating PPARα [43, 45] ; -decreasing ROS [42] ; Citrus aurantium L Naringenin/hesperetin -antioxidant [47] ; -antiatherogenic [48] and antidepressant [46] -increasing expression of BDNF [46] ; -activating PPAR; -up-regulating adiponectin expression [48] Cell cultures; rodent models Pinellia ternata lectin -pro-inflammatory [51] ; -anti-cancer [49] ; anti-tumor [50] ; -increasing steroid biosynthesis [52] -inhibits cell proliferation and metastasis [49] ; -inhibiting ERK activation [52] and activating NF-κB [51] Cell cultures; rodent models Haw pectin pentasaccharide -anti-inflammatory [53] ; -antioxidant [55] ; -lowering blood cholesterol [56] and anti-atherogenic [54] -activating PPARα and acyl-CoA oxidase [55] Cell cultures; rodent models Fructus mume extract -alleviating cognitive impairments [57] and anti-inflammatory [58] -down-regulation of TLR4 and p38 MAPK signaling [58] Cell cultures; rodent models Trichosanthin -anti-tumor [59] ; anti-HIV; immunosuppressive [60] -inhibiting cell growth and inducing apoptosis [59] Cell cultures; rodent models Abbreviations: BDNF, brain derived neurophic factor; C/EBP-α, CCAAT enhancer binding protein-α; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; ROS, reactive oxygen species; TGF-β, transforming growth factor-β. Baicalin reduced renal fibrosis through down-regulating transforming growth factor-β/Smad pathway [43] . It also had a protective effect on T2DM via improving islet β-cell function [44] . Furthermore, wogonin alleviated diabetic cardiomyopathy, diabetes-related cognitive deficits, and metabolic syndrome [45] [46] [47] . Wogonin improved peroxisome proliferator-activated receptor (PPAR)-α (PPAR-α) activity in adipocytes and type 1 diabetic mice [48] . Flavanones naringenin and hesperetin from Citrus aurantium L exhibited anti-depressant [49] , antioxidant [50] , and anti-atherogenic [51] effects. Pinellia ternate had anti-cancer [52, 53] and pro-inflammatory [54] actions. It also attenuated mucus secretion and airway inflammation in rats with chronic obstructive pulmonary disease [55] . Crataegus pinnatifida Bunge exerted anti-inflammatory effects [56] and decreased the risks of cardiovascular diseases by lowering blood cholesterol [57] [58] [59] . Fructus mume exhibited neuroprotective effect through down-regulating inflammation and inhibiting TLR4 and p38 MAPK signaling [60, 61] . Radix Trichosanthis played anti-cancer [62] and immunosuppressive [63] roles. The combination of these components in Tangminling pill might exert more beneficial effects in T2DM patients. In our study, the safety of Tangminling pill was also confirmed, without serious adverse events reported in the included RCTs. However, the production of traditional Chinese medicine is very complicated, so it is necessary to test the effectiveness and safety of each plant extract and investigate easier preparation methods of the pill formulation. T2DM is a chronic metabolic disease in which the deterioration of glycemic control is associated with progressive islet β-cell dysfunction, chronic inflammation, oxidation, and lipid metabolic disturbance. Metabolic syndrome is characterized by the presence of abdominal obesity, IR, hyperglycemia, dyslipidemia, and hypertension [64] . Tangminling pill significantly improved pancreatic β-cell function and reduced BMI and WC in T2DM patients in our analyses. The anti-hyperglycemic effect of traditional Chinese medications might be attributed in part to the β-cell protection through activating AMPK signaling [65] . Tangminling was found to increase glucose transporter 4 (GLUT4) level and AMPK activity in skeletal muscle [66] and promote insulin secretion through up-regulating PPARα [67] . It might also promote the proliferation and differentiation of pancreatic β-cells and therefore postpone the exhaustion of β-cell function. Tangminling was showed to improve insulin sensitivity [68] , which might be another potential mechanism to regulate glucose metabolic disorder. Hypoglycemia has been considered as a major barrier to the proper glycemic control in diabetic patients [69] . Our analyses revealed that Tangminling reduced blood glucose mildly, without hypoglycemic events reported. Tangminling treatment might significantly decrease the risk of hypoglycemia, which result in a better quality of life for T2DM patients. Besides, significant heterogeneity existed in the analyses of FPG, BMI, WC, and HOMA-IR. There was a significant disparity in sample sizes among the four RCTs included in our pooled analyses. In fact, among the 767 patients included in the analyses, 399 (52.0%) were from one study [8] . However, after excluding this study, no substantial alteration was found in pooled WMDs. Several limitations should be considered in our analyses. The sample sizes were relatively small, and the number of included studies was limited, both of which might limit the power to estimate the effects of Tangminling pill on T2DM. Intervention and follow-up durations of some studies were relatively short. Therefore, more high-quality studies with more extended intervention and larger sample sizes are needed. Despite the above limitations, this systematic analysis was more convincing than any previous single study. Indeed, our analysis has some notable strengths. It strictly adhered to the guidelines and only RCT studies were included, which helps to increase the robustness of the conclusions. In addition, the parameters used to assess the clinical outcomes are strict, which can increase the validity of our study. To the best of our knowledge, this is the first pooled analysis to assess the effect of one traditional Chinese medication, Tangminling pill, on T2DM. Tangminling pill is effective and safe for glycemic control and β-cell function in T2DM patients, and it could be used to treat T2DM as a promising complementary approach. However, more rigorously designed trials are warranted to investigate the impacts of Tangminling pill on diabetes and diabetic complications. The authors declare that there are no competing interests associated with the manuscript. P.H. conceptualized the topic, interpreting the results and finalizing the manuscript. J.C., J.Z. and Y.L. conducted the systematic search on bibliographic databases for article retrieval, selection of articles, data extraction, and quality assessment. J.C., J.Z. and Y.L. performed the statistical analysis and wrote the manuscript draft. P.H. provided supervision of the study conduct and revised the manuscript. All authors read and approved the final manuscript. International Diabetes Federation (2017) International Diabetes Federation, 8th , IDF Diabetes Atlas Associations of dietary glucose, fructose, and sucrose with β-cell function, insulin sensitivity, and type 2 diabetes in the Maastricht study The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis Daily intake of grape powder prevents the progression of kidney disease in obese type 2 diabetic ZSF1 Rats The "Metabolic Memory" theory and the early treatment of hyperglycemia in prevention of diabetic complications Genetics of cardiovascular and renal complications in diabetes Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial Traditional Chinese medication for cardiovascular disease The impact of tang-min-ling pills on islet β-cell function in diabetic patients with metabolic syndrome Multi-center randomized controlled and double blind trial of Tang-min-ling pills in the treatment of type2 diabetes mellitus Effect of Tangminling pills on β-cell function of patients with type 2 diabetic combined metabolism syndrome Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials Clopidogrel 150 vs. 75 mg day(-1) in patients undergoing percutaneous coronary intervention: a meta-analysis Noninvasive ventilation improves cardiac function in patients with chronic heart failure The anti-hyperglycemic effect of plants in genus Gynura cass Retrospective study of Traditional Chinese Medicine treatment of type 2 diabetes mellitus A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: a randomized placebo-controlled double-blind study Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/-mice with hyperhomocysteinemia Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE-/-mice Berberine affects osteosarcoma via downregulating the caspase-1/IL-1beta signaling axis Dose dependent dual effect of Baicalin and herb Huang Qin extract on angiogenesis Non-coding RNAs and Berberine: a new mechanism of its anti-diabetic activities Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states TNF alpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling Berberine suppresses proinflammatory responses through AMPK activation in macrophages Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress Coptisine prevented IL-beta-induced expression of inflammatory mediators in chondrocytes Neuroprotective activity of coptisine from Coptis chinensis (Franch) Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides Renoprotective effect of the Shen-Yan-Fang-Shuai formula by inhibiting TNF-α/NF-κB signaling pathway in diabetic rats Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells Antiviral effects of saikosaponins on human coronavirus 229E in vitro Saikosaponin a induces apoptosis through mitochondria-dependent pathway in hepatic stellate cells Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis Antidepressant-like effects of the Radix Bupleuri and Radix Paeoniae Alba drug pair The inhibition of mast cell activation of Radix Paeoniae alba extraction identified by TCRP based and conventional cell function assay systems High doses of baicalin induces kidney injury and fibrosis through regulating TGF-β/Smad signaling pathway Baicalein protects against Type 2 diabetes via promoting islet beta-cell function in obese diabetic mice Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties Wogonin ameliorates hyperglycemia and dyslipidemia via PPARalpha activation in db/db mice Baicalin alleviates diabetesassociated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brainderived neurotrophic factor and apoptosis Wogonin suppresses osteopontin expression in adipocytes by activating PPARalpha Antidepressant-like effect of the water extract of the fixed combination of Gardenia jasminoides, Citrus aurantium and Magnolia officinalis in a rat model of chronic unpredictable mild stress Structural characterization and antioxidant activities of polysaccharides from Citrus aurantium L Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67kDa Laminin Receptor (LR) Study on anti-Ehrlich ascites tumour effect of Pinellia ternata polysaccharide in vivo Pinellia ternata lectin exerts a pro-inflammatory effect on macrophages by inducing the release of pro-inflammatory cytokines, the activation of the nuclear factor-kappaB signaling pathway and the overproduction of reactive oxygen species Pinellia ternata attenuates mucus secretion and airway inflammation after inhaled corticosteroid withdrawal in COPD rats Anti-inflammatory effect of the water fraction from hawthorn fruit on LPS-stimulated RAW 264.7 cells Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits Effects of pectin pentaoligosaccharide from Hawthorn (Crataegus pinnatifida Bunge. var. Major ) on the activity and mRNA levels of enzymes involved in fatty acid oxidation in the liver of mice fed a high-fat diet Comparative effects of hawthorn (Crataegus pinnatifida Bunge) pectin and pectin hydrolyzates on the cholesterol homeostasis of hamsters fed high-cholesterol diets Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review Research progress on immunosuppressive activity of monomers extracted from Chinese medicine A review on the protective effects of honey against metabolic syndrome Jinlida granule inhibits palmitic acid induced-intracellular lipid accumulation and enhances autophagy in NIT-1 pancreatic β cells through AMPK activation Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats Effect of Tang Min Ling pill on PPARα and insulin secretion Influence of Kaiyuqingre formula on glycolipin metabolism in spontaneous obese T2DM rats. Chin Carbohydrate counting in children and adolescents with type 1 diabetes AMPK, AMP-activated protein kinase; BMI, body mass index; CI, confidence interval; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HOMA, homeostatic model assessment; IR, insulin resistance; I 2 , inconsistency index; Nfs, fail-safe number; PPAR, peroxisome proliferator-activated receptor; RCT, randomized controlled trial; T2DM, type 2 diabetes mellitus; WC, waist circumference; WMD, weighted mean difference; 2-hr PG, 2-h postprandial glucose.